Lukas Marti

Lukas Marti

Auto-generated profile, based on publicly available information

Lukas Marti

Department of General, Visceral, Endocrine and Transplant Surgery, Cantonal Hospital of St. Gallen, St. Gallen, Switzerland

Research Focus & Metrics

Academic Career Length

26Years (2001-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
28 July 2016 in BMC Cancer
Verified
Journal Article
Open access
PDF file
RWRene Warschkow
Rene Warschkow
MSMichael C. Sulz
Michael C. Sulz
LMLukas Marti
Lukas Marti
ITIgnazio Tarantino
Ignazio Tarantino
BSBruno M. Schmied
Bruno M. Schmied
UGUlrich Güller
Ulrich Güller
The distinction between right-sided and left-sided colon cancer has recently received considerable attention due to differences regarding underlying genetic mutations. There is an ongoing debate if right- versus left-sided tumor location itself represents an independent prognostic factor. We aimed to investigate this question by using propensity score matching. Patients with resected, stage I - III colon cancer were identified from the Surveillance, Epidemiology, and End Results (SEER) database (2004–2012). Both univariable and multivariable Cox regression as well as propensity score matching were used. Overall, 91,416 patients (51,937 [56.8 %] with right-sided, 39,479 [43.2 %] with left-sided colon cancer; median follow-up 38 months) were eligible. In univariable analysis, patients with right-sided cancer had worse overall (hazard ratio [HR] = 1.32, 95 % CI:1.29–1.36, P < 0.001) and cancer-specific survival (HR = 1.26, 95 % CI:1.21–1.30, P < 0.001) compared to patients with left-sided cancer. After propensity score matching, the prognosis of right-sided carcinomas was better regarding overall (HR = 0.92, 95 % CI: 0.89 − 0.94, P < 0.001) and cancer-specific survival (HR = 0.90, 95 % CI:0.87 − 0.93, P < 0.001). In stage I and II, the prognosis of right-sided cancer was better for overall (HR = 0.89, 95 % CI:0.84–0.94 and HR = 0.85, 95 % CI:0.81–0.89) and cancer-specific survival (HR = 0.71, 95 % CI:0.64 − 0.79 and HR = 0.75, 95 % CI:0.70–0.80). Right- and left-sided colon cancer had a similar prognosis for stage III (overall: HR = 0.99, 95 % CI:0.95–1.03 and cancer-specific: HR = 1.04, 95 % CI:0.99–1.09). This population-based analysis on stage I - III colon cancer provides evidence that the prognosis of localized right-sided colon cancer is better compared to left-sided colon cancer. This questions the paradigm from previous research claiming a worse survival in right-sided colon cancer patients.

10 April 2017 in Journal of Gastroenterology
Verified
Journal Article
Closed access
PDF file
SESabrina Maria Ebinger
Sabrina Maria Ebinger
JHJulia Hardt
Julia Hardt
RWRené Warschkow
René Warschkow
BSBruno Martin Schmied
Bruno Martin Schmied
AHAlexander Herold
Alexander Herold
LMLukas Marti
Lukas Marti

30 January 2019 in Journal of Neurogastroenterology and Motility
Verified
Journal Article
Open access
PDF file
BWBernhard Widmann
Bernhard Widmann
CGChristian Galata
Christian Galata
RWRene Warschkow
Rene Warschkow
UBUlrich Beutner
Ulrich Beutner
ÖÖÖnder Ögredici
Önder Ögredici
LMLukas Marti
Lukas Marti
Bernhard Widmann, Christian Galata, Rene Warschkow, Ulrich Beutner, Önder Ögredici, Franc H Hetzer, Bruno M Schmied, Stefan Post, and Lukas Marti. J Neurogastroenterol Motil 2019;25:159-70. https://doi.org/10.5056/jnm17106

25 October 2011 in Journal of Hepato-Biliary-Pancreatic Sciences
Verified
Journal Article
Closed access
RWRene Warschkow
Rene Warschkow
KUKristjan Ukegjini
Kristjan Ukegjini
ITIgnazio Taratino
Ignazio Taratino
TSThomas Steffen
Thomas Steffen
SMSascha A. Müller
Sascha A. Müller
LMLukas Marti
Lukas Marti

22 April 2020 in coloproctology
Verified
Journal Article
Closed access
PDF file
LMLukas Marti
Lukas Marti
SPStefan Post
Stefan Post
AHAlexander Herold
Alexander Herold
OSOliver Schwandner
Oliver Schwandner
FHFranc Hetzer
Franc Hetzer
SESabrina M. Ebinger
Sabrina M. Ebinger

18 January 2017 in Gastroenterology Research and Practice
Verified
Journal Article
Open access
PDF file
RWRene Warschkow
Rene Warschkow
SESabrina M. Ebinger
Sabrina M. Ebinger
WBWalter Brunner
Walter Brunner
BSBruno M. Schmied
Bruno M. Schmied
LMLukas Marti
Lukas Marti
Background.Abdominoperineal resection (APR) has been associated with impaired survival in nonmetastatic rectal cancer patients. It is unclear whether this adverse outcome is due to the surgical procedure itself or is a consequence of tumor-related characteristics.Study Design.Patients were identified from the Surveillance, Epidemiology, and End Results database. The impact of APR compared to coloanal anastomosis (CAA) on survival was assessed by Cox regression and propensity-score matching.Results.In 36,488 patients with rectal cancer resection, the APR rate declined from 31.8% in 1998 to 19.2% in 2011, with a significant trend change in 2004 at 21.6% (P<0.001). To minimize a potential time-trend bias, survival analysis was limited to patients diagnosed after 2004. APR was associated with an increased risk of cancer-specific mortality after unadjusted analysis (HR = 1.61, 95% CI: 1.28–2.03,P<0.01) and multivariable adjustment (HR = 1.39, 95% CI: 1.10–1.76,P<0.01). After optimal adjustment of highly biased patient characteristics by propensity-score matching, APR was not identified as a risk factor for cancer-specific mortality (HR = 0.85, 95% CI: 0.56–1.29,P=0.456).Conclusions.The current propensity score-adjusted analysis provides evidence that worse oncological outcomes in patients undergoing APR compared to CAA are caused by different patient characteristics and not by the surgical procedure itself.